ENOV
Price
$21.79
Change
-$9.58 (-30.54%)
Updated
Feb 3 closing price
Capitalization
1.25B
22 days until earnings call
Intraday BUY SELL Signals
ZBH
Price
$86.18
Change
-$11.19 (-11.49%)
Updated
Feb 3 closing price
Capitalization
17.08B
6 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENOV vs ZBH

Header iconENOV vs ZBH Comparison
Open Charts ENOV vs ZBHBanner chart's image
Enovis
Price$21.79
Change-$9.58 (-30.54%)
Volume$1.45M
Capitalization1.25B
Zimmer Biomet Holdings
Price$86.18
Change-$11.19 (-11.49%)
Volume$1.2M
Capitalization17.08B
ENOV vs ZBH Comparison Chart in %
View a ticker or compare two or three
VS
ENOV vs. ZBH commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a Hold and ZBH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (ENOV: $21.79 vs. ZBH: $86.18)
Brand notoriety: ENOV and ZBH are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ENOV: 143% vs. ZBH: 57%
Market capitalization -- ENOV: $1.25B vs. ZBH: $17.08B
ENOV [@Medical/Nursing Services] is valued at $1.25B. ZBH’s [@Medical/Nursing Services] market capitalization is $17.08B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $189.57B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENOV’s FA Score shows that 0 FA rating(s) are green whileZBH’s FA Score has 1 green FA rating(s).

  • ENOV’s FA Score: 0 green, 5 red.
  • ZBH’s FA Score: 1 green, 4 red.
According to our system of comparison, ZBH is a better buy in the long-term than ENOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENOV’s TA Score shows that 4 TA indicator(s) are bullish while ZBH’s TA Score has 2 bullish TA indicator(s).

  • ENOV’s TA Score: 4 bullish, 4 bearish.
  • ZBH’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, ENOV is a better buy in the short-term than ZBH.

Price Growth

ENOV (@Medical/Nursing Services) experienced а -0.86% price change this week, while ZBH (@Medical/Nursing Services) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.78%. For the same industry, the average monthly price growth was +2.20%, and the average quarterly price growth was +14.35%.

Reported Earning Dates

ENOV is expected to report earnings on Feb 26, 2026.

ZBH is expected to report earnings on Feb 10, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.78% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZBH($17.1B) has a higher market cap than ENOV($1.25B). ZBH YTD gains are higher at: -4.159 vs. ENOV (-18.206). ZBH has higher annual earnings (EBITDA): 2.38B vs. ENOV (-995.45M). ENOV has less debt than ZBH: ENOV (1.44B) vs ZBH (8.11B). ZBH has higher revenues than ENOV: ZBH (8.01B) vs ENOV (2.23B).
ENOVZBHENOV / ZBH
Capitalization1.25B17.1B7%
EBITDA-995.45M2.38B-42%
Gain YTD-18.206-4.159438%
P/E RatioN/A21.38-
Revenue2.23B8.01B28%
Total Cash33.6MN/A-
Total Debt1.44B8.11B18%
FUNDAMENTALS RATINGS
ENOV vs ZBH: Fundamental Ratings
ENOV
ZBH
OUTLOOK RATING
1..100
5355
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9780
PRICE GROWTH RATING
1..100
8763
P/E GROWTH RATING
1..100
9847
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZBH's Valuation (16) in the Medical Specialties industry is somewhat better than the same rating for ENOV (78) in the Industrial Machinery industry. This means that ZBH’s stock grew somewhat faster than ENOV’s over the last 12 months.

ZBH's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that ZBH’s stock grew similarly to ENOV’s over the last 12 months.

ZBH's SMR Rating (80) in the Medical Specialties industry is in the same range as ENOV (97) in the Industrial Machinery industry. This means that ZBH’s stock grew similarly to ENOV’s over the last 12 months.

ZBH's Price Growth Rating (63) in the Medical Specialties industry is in the same range as ENOV (87) in the Industrial Machinery industry. This means that ZBH’s stock grew similarly to ENOV’s over the last 12 months.

ZBH's P/E Growth Rating (47) in the Medical Specialties industry is somewhat better than the same rating for ENOV (98) in the Industrial Machinery industry. This means that ZBH’s stock grew somewhat faster than ENOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENOVZBH
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
61%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
58%
Advances
ODDS (%)
Bullish Trend 27 days ago
60%
Bullish Trend 6 days ago
62%
Declines
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 1 day ago
57%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
59%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ENOV
Daily Signal:
Gain/Loss:
ZBH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBMX91.343.10
+3.51%
Rydex Basic Materials A
TSMWX16.54-0.02
-0.12%
Nuveen Quant Small/Mid Cap Eq R6
SAPYX34.99-0.19
-0.54%
ClearBridge Appreciation I
RGCEX16.61-0.13
-0.78%
Columbia Select Global Equity C
SNIGX84.87-1.43
-1.66%
Sit Large Cap Growth

ENOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with FELE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then FELE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENOV
1D Price
Change %
ENOV100%
-1.71%
FELE - ENOV
56%
Loosely correlated
+0.61%
IART - ENOV
56%
Loosely correlated
-3.41%
CNMD - ENOV
56%
Loosely correlated
-1.07%
DOV - ENOV
55%
Loosely correlated
+2.09%
PH - ENOV
53%
Loosely correlated
+1.30%
More

ZBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with IART. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then IART could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBH
1D Price
Change %
ZBH100%
-0.05%
IART - ZBH
52%
Loosely correlated
-3.41%
ENOV - ZBH
48%
Loosely correlated
-1.71%
AVNS - ZBH
46%
Loosely correlated
-0.37%
HOLX - ZBH
43%
Loosely correlated
-0.15%
SYK - ZBH
43%
Loosely correlated
-1.99%
More